AGT and dementia: Cohen et al. [20] reported no significant difference in risk of dementia or MCI in patients receiving Ang-II stimulating AHMs compared with patients taking Ang-II inhibiting AHMs (HR = 0.90; 95% CI = 0.72–1.12).